Pharmaceutical Biology · 2010 · 30 citations · 17 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyOncogenesMalignant NeoplasmsTumor HistopathologyAnticancer ActivityAnticancer Mechanism Of ActionAnticancer Natural ProductsCancer Cell Culture ModelsCancer Cell Proliferation InhibitionImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical Staining
Matrine, one of the main active components extracted from dry roots of Sophora flavescens Ait (Leguminosae), has been reported to have anticancer effects on a number of cancer cell lines, but the anticancer mechanism of matrine remains elusive. This study shows that matrine also displays anticancer activity on human hepatocellular carcinoma (HepG2) cells. In this work, the optimal cultivation condition for HepG2 cells was determined using the combinatorial orthogonal test design [L18 (21 x 37)]. Exposure of HepG2 cells to matrine resulted in inhibition of proliferation in both a time- and dose-dependent manner, as measured by morphology observation, hematoxylin and eosin (H&E) staining, and MTT assay (p<0.05). Further immunohistochemical analyses revealed that the expression of alpha fetal protein (AFP), proliferating cell nuclear antigen (PCNA), C-myc and Bcl-2 was down-regulated significantly, but the expression of Bax was up-regulated higher than untreated cells. The results demonstrated that matrine inhibited HepG2 cells proliferation primarily via up-regulating or down-regulating expression of the tumor relevant proteins.
17
Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling
James J. Chou, Honglin Li, Guy S. Salvesen et al. · Cell · 1999 · 480 citations · Full text
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
Gustavo Leone, James DeGregori, Rosalie C. Sears et al. · Nature · 1997 · 468 citations
Efficacy of intramuscular matrine in the treatment of chronic hepatitis B.
Yao Long, Xiao-Tian Lin, Kun-Lun Zeng et al. · PubMed · 2004 · 110 citations